Challenges in the diagnosis & treatment of bipolar depression - Part 2: Treatment options

Journal of Psychosocial Nursing and Mental Health Services

Volumn 44, Issue 5, 2006, Pages 9-12

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744932716     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20060501-03     Document Type: Review

References (27)

1. th ed., Text Rev.). Washington, DC: Author.
2. Bauer, M., London, E.D., Rasgon, N., Berman, S.M., Frye, M.A., Altshuler, L.L., et al. (2005). Supraphysiological doses of levothyroxine alter regional cerehral metabolism and improve mood in bipolar depression. Molecular Psychiatry, 10, 456-469.
3. Benedetti, F., Barbini, B., Florita, M., Fulgosi, M.C., Pontiggia, A., Campori, E., et al. (2005). Treatment: Rapid improvement in information processing after sleep deprivation and sleep phase-advance in bipolar depression. Clinical Neuropsychiatry: Journal of Treatment Evaluation, 2, 180-182.
4. Bowden, C.L. (2005). Treatment options for bipolar depression. Journal of Clinical Psychiatry, 66(Suppl. 1), 3-6.
5. Calabrese, J.R., Elhaj, O., Gajwani, P., & Gao, K. (2005). Clinical highlights in bipolar depression: Focus on atypical antipsychotics. Journal of Clinical Psychiatry, 66(Suppl. 5), 26-33.
6. Carlson, P.J., Merlock, M.C., & Suppes, T (2004). Adjunctive stimulant use in patients with bipolar disorder: Treatment of residual depression and sedation. Bipolar Disorders, 6, 416-420.
7. Davis, L.L., Bartolucci, A., & Petty, F. (2005). Divalproex in the treatment of bipolar depression: A placebo-controlled study, Journal of Affective Disorders, 85, 259-266.
8. Fawcett, J.A. (2003). Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression. Journal of Clinical Psychiatry, 64(Suppl. 5), 32-37.
9. George, M.S., Rush, A.J., Marangell, L.B., Sackeim, H.A., Brannan, S.K., Davis, S.M., et al. (2005). A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry, 58, 364-373.
10. Ghaemi, S.N., Rosenquist, K.J., Ko, J.Y., Baldassano, C.F., Kontos, N.J., & Baldessarini, R.J. (2004). Antidepressant treatment in bipolat versus unipolar depression. American Journal of Psychiatry, 161, 163-165.
11. Gijsman, H.J., Geddes, J.R., Rendell, J.M., Nolen, W.A., & Godwin, G.M. (2004). Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. American Journal of Psychiatry, 161, 537-1547.
12. Goldberg, J.F., Burdick, K.E., & Endick, C.J. (2004). Preliminary randomized double-blind placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. American Journal of Psychiatry, 161, 564-566.
13. Goodwin, F.K., Fireman, B., Simon, G.E., Hunkeler, E.M., Lee, J., & Revicki, D. (2003). Suicide risk in bipolar disorder during treatment with lithium and divalproex. Journal of the American Medical Association, 290, 1467-1473.
14. Grunze, H. (2005). Reevaluating therapies for bipolar depression. Journal of Clinical Psychiatry, 66(Suppl. 5), 17-25.
15. Kessing, L.V., Sondergard, L., Kvist, K., & Andersen, P.K. (2005). Suicide risk in patients treated with lithium. Archives of General Psychiatry, 62, 860-866.
16. Leverich, G.S., Altshuler, L.L., Frye, M.A., Suppes, T., McElroy, S.L., Keck, P.E., et al. (2006). Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. American Journal of Psychiatry, 163, 232-239.
17. Li, X., Nahas, Z., Anderson, B., Kozel, F.A., & George, M.S. (2004). Can left pre-frontal rTMS be used as a maintenance treatment for bipolar depression? Depression and Anxiety, 20, 98-100.
18. McIntyre, R.S., Mancini, D.A., McCann, S., Srinivasan, J., Sagman, D., & Kennedy, S.H. (2002). Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study. Bipolar Disorders, 4, 207-213.
19. Mitchell, P.B., & Malhi, G.S. (2004). Bipolar depression: Phenomenological overview and clinical characteristics. Bipolar Disorders, 6, 530-539.
20. Nierenberg, A.A., Ostacher, M.J., Calabrese, J.R., Ketter, T.A., Marangell, LB., Miklowitz, D.J., et al. (2006). Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. American Journal of Psychiatry, 163, 210-216.
21. Osher, Y., Bersudsky, Y., & Belmaker, R.H. (2005). Omega-3 eicosapentaenoic acid in bipolar depression: Report of a small open-label study. Journal of Clinical Psychiatry, 66, 726-729.
22. Post, R.M. (2005). The impact of bipolar depression. Journal of Clinical Psychiatry, 66(Suppl. 5), 5-10.
23. Rohan, M., Parow, A., Stoll, A.L., Demopulos, C., Friedman, S., Dager, S., et al, (2004). Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. American Journal of Psychiatry, 161, 93-98.
24. Sharma, V., Khan, M., & Smith, A. (2005). A closer look at treatment resistant depression: Is it due to a bipolar diathesis? Journal of Affective Disorders, 84, 251-257.
25. Thase, M.E. (2005). Bipolar depression: Issues in diagnosis and treatment. Harvard Review of Psychiatry, 13, 257-271.
26. Vieta, E. (2005). The package of care for patients with bipolar depression. Journal of Clinical Psychiatry, 66(Suppl. 5), 34-39.
27. Zarate, C.A., Quiroz, J.A., Singh, J.B., Denicoff, K.D., DeJesus, G., Luckenbaugh, D.A., et al. (2005). An open-label trial of the glutamate-modulating agent riluzole in combination with the treatment of bipolar depression. Biological Psychiatry, 57, 430-432.